Tuesday, April 3, 2012
Another NYT article about generic drug cases
Here is a link to another article/editorial in the New York Times criticizing the effects of the Supreme Court's decision in Pliva v. Mensing. It starts by saying "[d]ozens of suits against drug companies have been dismissed in federal and state courts because of a decision by the Supreme Court last year that makes it virtually impossible to sue generic manufacturers for failing to provide adequate warning of a prescription drug’s dangers. This outrageous denial of a patient’s right to recover fair damages makes it imperative that Congress or the Food and Drug Administration fashion a remedy" You can read the full article here.